Endometriosis After “Pelvic Cleanout”

article OA: closed CC0 ⤵ 9 in-corpus citations
View on OpenAlex View on PubMed View at publisher
AI-generated summary by gemini-2.5-flash-lite, 2026-06-08

A 31-year-old woman developed an endometrioma above the vaginal apex five years after hysterectomy and four years after bilateral salpingo-oophorectomy for a pelvic abscess, despite no prior evidence of endometriosis.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

In many patients endometriosis is ultimately treated by total abdominal hysterectomy and bilateral salpingo-oophorectomy. Endometriosis in a 31-year-old, white, multiparous woman demonstrates the unusual nature of this disease. Five years after a total abdominal hysterectomy and four years after a bilateral salpingo-oophorectomy for a pelvic abscess, she had an endometrioma above the apex of the vagina. Her previous surgery had revealed no evidence of endometriosis. This patient's age, parity, and previous pelvic cleanout made her an unusual candidate for this disease.

My notes (saved in your browser only)

Condition tags

endometriosisendometrioma

MeSH descriptors

Castration Endometriosis Fallopian Tubes Hysterectomy Pelvic Neoplasms Postoperative Complications Adult Endometriosis Fallopian Tubes Female Humans Pelvic Neoplasms Time Factors

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

Cited by (9)

Source provenance

europepmc
last seen: 2026-09-13T09:25:22.628771+00:00
openalex
last seen: 2026-06-10T17:14:06.276822+00:00
pubmed
last seen: 2026-05-14T05:58:53.789372+00:00
unpaywall
last seen: 2026-09-13T06:26:10.529621+00:00
License: CC0 · commercial use OK